Ryan Jason
- SEC CIK
- 0001585017
No open-market purchases or sales filed in the past year.
Current role at each company
- WGS GeneDx Holdings Corp.Directoras of Jun 23, 2026
- OMIC Singular Genomics Systems, Inc.Directoras of Feb 25, 2025
- SLGC SomaLogic, Inc.Directoras of Jan 9, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ryan Jason as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
WGS GeneDx Holdings Corp.
Director7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2025 (view filing) | Aug 27 | Same day | Ryan JasonDirector | SSaleClass A Common Stock | −38.1K | $127.30 | −$4.85M | −26.9%103.3K after | 6 lots |
| Aug 27, 2025 (view filing) | Aug 27 | Same day | Ryan JasonDirector | SSaleClass A Common Stock | −1.15K | $129.65 | −$149.1K | −8.8%11.9K after | |
| Nov 21, 2024 (view filing) | Nov 19-20 | 2 days | Ryan JasonDirector | SSaleClass A Common Stock | −47.0K | $70.57 | −$3.32M | −100.0%0 after | 6 lots |
| Nov 20, 2023 (view filing) | Nov 16-17 | 4 days | Ryan JasonExecutive Chairman | PPurchaseClass A Common Stock | +114.7K | $1.41 | +$161.4K | New position114.7K after | 2 lots |
| Oct 18, 2023 (view filing) | Oct 17 | 1 day | Ryan JasonExecutive Chairman | SSaleClass A Common Stock | −42 | $3.19 | −$133.98 | −0.7%5.83K after | |
| Jan 4, 2023 (view filing)7:46 PM ET | Dec 31, 2022 | 4 days | Ryan JasonExecutive Chairman | SSaleClass A Common Stock | −73.7K | $0.2619 | −$19.3K | −28.0%189.6K after | |
| Oct 18, 2022 (view filing) | Oct 17 | 1 day | Ryan JasonExecutive Chairman | SSaleClass A Common Stock | −1.28K | $0.86 | −$1.10K | −7.5%15.8K after |